4.6 Article

Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450

Journal

BIOTECHNOLOGY AND BIOENGINEERING
Volume 93, Issue 3, Pages 494-499

Publisher

WILEY
DOI: 10.1002/bit.20744

Keywords

cytochrome P450BM3; drug metabolites; drug metabolism; bioconversion; peroxide shunt; directed evolution

Funding

  1. NIGMS NIH HHS [R01 GM068664-01] Funding Source: Medline

Ask authors/readers for more resources

Testing the toxicities and biological activities of the human metabolites of drugs is important for development of safe and effective pharmaceuticals. Producing these metabolites using human cytochrome P450s is difficult, however, because the human enzymes are costly, poorly stable, and slow. We have used directed evolution to generate variants of P450 BM3 from Bacillus megaterium that function via the peroxide shunt pathway, using hydrogen peroxide in place of the reductase domain, oxygen and NADPH. Here, we report further evolution of the P450 BM3 heme domain peroxygenase to enhance production of the authentic human metabolites of propranolol by this biocatalytic route. This system offers a versatile, cost-effective, and scaleable route to the synthesis of drug metabolites. (c) 2005 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available